spacer
home > pmps > summer 2002 > mes or mess? - the creation of management information and the effective use of production data in pharmaceutical manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

MES or Mess? - The Creation of Management Information and the Effective Use of Production Data in Pharmaceutical Manufacturing

As a participant in the IT industry and one that has implemented a wide variety of production information systems in several industries, I have seen all too many buzzwords come and go. The name of the game today is management execution systems (MES). According to the hype, MES delivers totally integrated information systems from the production line to the boardroom - a thrilling thought! This article will look at the different areas that are involved in MES and analyse the different data and information needs from the various participants in the production, delivery and decision processes.

Although Table 1 is not exhaustive - neither when it comes to describing the needs of each and every role, nor all the possible roles involved in the production process - it is sufficient for the purpose of analysing the various aspects of an MES system and the fundamental differences in information needs throughout the information chain.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Espen Gisvold, Managing Director of ESGH Espen Gisvold is the Managing Director of ESGH. He graduated from the University of Oslo, Norway in 1985 in Mathematics, Physics and Informatics and gained a Bachelor's degree in Informatics, which focused on numerical analysis.
Subsequently, Espen spent 10 years working with Saga Petroleum ASA, where he subsequently established and was responsible for the production information management system for the operations division. In 1996, Espen joined Inenco - a software house specialising in MES systems - as Product Quality Manager. In May 2000, he moved to Agilent Technologies as Test Lead Engineer.

spacer
Espen Gisvold
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

The need for a blueprint emergency plan to avoid a HPAPI crisis

SMi reports: Taro Pharmaceuticals, Purdue Pharma and Sakari Consultants to present at HPAPI USA taking place on October 21st – 22nd in Boston
More info >>

White Papers

Future-proofing serialization solutions: the importance of strong level 3 capabilities

Adents

The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >>

 
Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals – gaining strong, new industry contacts and building on existing ones.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement